Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
buprenorphine (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
methadone (methadose) (1 trial)
ribavirin (virazole) (1 trial)
chloroquine (1 trial)
cyclosporine (sandimmune) (1 trial)
infliximab (remicade) (1 trial)
leflunomide (arava) (1 trial)
naltrexone (revia) (1 trial)
sulfasalazine (azulfidine) (1 trial)
uro vaxom (1 trial)
temozolomide (temodar) (1 trial)
Arthritis (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Trials (3 total)
Trial APIs (12 total)